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ABSTRACT
Two main features common to all solid tumors are tissue hypoxia and 
inflammation, both of which cause tumor progression, metastasis, therapy resistance 
and increased mortality. Chronic inflammation is associated with increased cancer 
risk, as demonstrated for inflammatory bowel disease patients developing colon 
cancer. However, the interplay between hypoxia and inflammation on the molecular 
level remains to be elucidated. We found that MC-38 mouse colon cancer cells contain 
functional hypoxic (HIF-1α) and inflammatory (p65/RelA) signaling pathways. In 
contrast to cells of the myeloid lineage, HIF-1α levels remained unaffected in MC-38 
cells treated with LPS, and hypoxia failed to induce NF-κB. A similar regulation of 
canonical HIF and NF-κB target genes confirmed these results. RNA deep sequencing 
of HIF-1α and p65/RelA knock-down cells revealed that a surprisingly large fraction of 
HIF target genes required p65/RelA for hypoxic regulation and a number of p65/RelA 
target genes required HIF-1α for proinflammatory regulation, respectively. Hypoxia 
attenuated the inflammatory response to LPS by inhibiting nuclear translocation of 
p65/RelA independently of HIF-1α, which was associated with enhanced IκBα levels 
and decreased IKKβ phosphorylation. These data demonstrate that the interaction 
between hypoxic and inflammatory signaling pathways needs to be considered when 
designing cancer therapies targeting HIF or NF-κB.
INTRODUCTION
The growth of solid tumors is associated with 
insufficient oxygen supply (hypoxia) and accompanied 
by leukocyte infiltration (inflammation), both of which 
further affect the metabolism of cancer cells, thereby 
regulating proliferation, metastasis and therapy efficacy 
[1]. Hypoxia-inducible factor (HIF) is the master regulator 
of the hypoxic response in cancer cells [2, 3]. HIFs are 
heterodimeric transcription factors consisting of one 
of three different oxygen-sensitive HIFα subunits and a 
common constitutive HIFα subunit. A family of prolyl-4-
hydroxylase domain (PHD) enzymes covalently modifies 
two proline residues within the oxygen-dependent 
degradation (ODD) domain of HIFα subunits. The PHD 
family comprises three members called PHD1, PHD2 and 
PHD3. Upon hydroxylation under normoxic conditions, 
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HIFα is bound by the von Hippel-Lindau (VHL) 
tumor suppressor protein and targeted for proteasomal 
destruction. The resulting high turnover rate of HIFα 
subunits allows for a very rapid stabilization under 
hypoxic conditions, affecting the transcriptional activity of 
several hundred target genes [4]. Therefore, tumor hypoxia 
and high HIFα levels are associated with poor prognosis of 
virtually all cancer types [5].
The association between inflammatory bowel 
disease and colon cancer is one example of how chronic 
inflammation can result in a pre-disposition to cancer 
[6]. Correspondingly, anti-inflammatory drugs decrease 
the incidence of cancer [7]. Invading inflammatory cells 
represent a remarkable proportion of the total tumor mass 
and are required for tumor angiogenesis and metastasis 
[8]. The nuclear factor (NF)-κB is the central transcription 
factor activated by inflammation. Canonical NF-κB 
activation is controlled by inhibitor of NF-κB (IκB) 
kinases (IKK), mainly IKK-κ, needed for phosphorylation-
induced degradation of IκB in response to infection and 
inflammation [9]. Like HIF-1α, NF-κB can be activated in 
tumors by extrinsic factors (e.g. autoimmune disease) or 
intrinsic factors (e.g. oncogenes) [7]. In cancer cells, NF-
κB regulates the expression of genes involved in several 
processes that play key roles in tumor progression such as 
proliferation, migration and apoptosis [10].
Whether or not NF-κB can also be induced by 
hypoxia is currently unclear. While some groups reported 
increased NF-κB activation under hypoxic conditions, 
others could not detect an increased NF-κB DNA-binding 
activity in hypoxic nuclear extracts, despite strongly 
induced HIF levels [11-16]. This could be explained by 
cell-type specific effects as well as by the severity and 
duration of the hypoxic stimulus which may vary among 
distinct transcription factors. However, in neutrophils 
HIF-1 has been suggested to induce NF-κB directly 
[12]. Moreover, IKK-β has been reported to be a specific 
PHD1 oxygen sensor target [13], and the ankyrin repeats 
of p105 NF-κB precursor and IκBα have been shown to 
be hydroxylated by factor inhibiting HIF (FIH), albeit 
without any functional consequences [17].
The gene encoding HIF-1α has been suggested to 
represent a direct NF-κB target [18-22]. So far, TNFα, 
oxidative stress and bacterial infections have been shown 
to activate HIF-1α gene transcription via NF-κB. A role for 
NF-κB in enhancing HIF-dependent tumor progression via 
inflammatory NF-κB activation has not been investigated 
yet. To better understand the mutual regulation of hypoxia 
and inflammation signaling pathways in cancer, we studied 
their interaction in the mouse colon carcinoma cell line 
MC-38.
RESULTS
The hypoxic response of MC-38 colon cancer cells 
is mediated by HIF-1
Mouse MC-38 colon adenocarcinoma cells were 
exposed to normoxia (21% oxygen) or hypoxia (0.2% 
oxygen) for 8 to 72 hours using conventional two-
dimensional (2D) dish culture, and mRNA levels of 
HIF-1α and HIF-2α were determined by RT-qPCR. 
Whereas hypoxia did not upregulate HIF-1α mRNA 
levels (Figure 1A), it robustly induced HIF-1α protein 
accumulation (Figure 1B). In contrast, only marginal 
HIF-2α mRNA levels (Figure 1A) and no HIF-2α protein 
(data not shown) could be detected, suggesting that HIF-
1 rather than HIF-2 mediates the hypoxic response in 
MC-38 cells. No difference in viability and only slightly 
decreased proliferation rates were observed under hypoxic 
conditions (data not shown). Transcript levels of the three 
canonical HIF target genes Glut1, Ca9 and Phd3 were 
found to be maximally upregulated by 12, 146 and 23-
fold, respectively, with different kinetics (Figure 1C).
A proinflammatory stimulus activates the NF-κB 
pathway in MC-38 colon cancer cells 
While the activation of the inflammatory NF-κB 
pathway by bacterial lipopolysaccharides (LPS) is well 
established mainly in the myeloid lineage, it is less clear 
whether all components of this pathway are also active 
in carcinoma cells. Therefore, we stimulated 2D cultured 
MC-38 colon cancer cells with LPS and analyzed p65/
RelA subcellular localization by immunofluorescence 
(Figure 2A) and by immunoblotting of nuclear extracts 
(Figure 2B). LPS induced nuclear translocation of 
p65/RelA, demonstrating a functional LPS signaling 
pathway resulting in NF-κB induction. This conclusion 
was confirmed by a robust transcriptional activation 
of canonical NF-κB target genes Tnfa and Cox2 which 
were maximally induced by 13- and 4-fold, respectively, 
with different kinetics (Figure 2C). Similarly, Il6 gene 
expression was upregulated 12-fold by LPS, though not 
reaching statistical significance (p = 0.054). 
NF-κB is not activated by hypoxia in MC-38 colon 
cancer cells
It has been suggested that hypoxia directly 
activates the NF-κB pathway by blocking PHD-
mediated hydroxylation of IKK-β, at least in HeLa 
cervical carcinoma cells [13]. However, in contrast to 
LPS treatment, exposure of MC-38 colon carcinoma 
cells to hypoxia for 0.5 to 4 hours did not induce 
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Figure 1: Hypoxic response of MC-38 cells. A. Time-dependent RT-qPCR quantification of HIF-1α and HIF-2α mRNA levels 
following exposure to hypoxia as indicated. B. Kinetics of hypoxic HIF-1α protein accumulation analysed by immunoblotting of 50 µg 
total protein extracts. C. Kinetics of hypoxic induction of canonical HIF target genes quantified by RT-qPCR of GLUT-1, CAIX and PHD3 
mRNA. Shown are mean values + SD of mRNA ratios relative to the constitutively expressed ribosomal protein S12 mRNA levels of n = 
3 independent experiments; *, p < 0.05; **, p < 0.01; ***, p < 0.001 (Student’s t-test).
Figure 2: Inflammatory response of MC-38 cells. A. Immunofluorescence microscopy of p65/RelA in MC-38 cells following 
treatment with 1 µg/ml LPS for 40 minutes. B. Immunoblot detection of p65/RelA and HDAC1 in nuclear extracts derived from MC-38 
cells following stimulation with 1 µg/ml LPS for 1 hour. C. Kinetics of inflammatory induction (1 µg/ml LPS for the time periods indicated) 
of canonical NF-κB target genes quantified by RT-qPCR of TNF-α, IL-6 and COX-2 mRNA. Shown are mean values + SD of mRNA ratios 
relative to the constitutively expressed ribosomal protein S12 mRNA levels of n = 3 to 4 independent experiments; **, p < 0.01 (Student’s 
t-test). 
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nuclear translocation of p65/RelA as shown by 
immunofluorescence (Figure 3A) and immunoblotting of 
nuclear extracts (Figure 3B), although HIF-1α proteins 
levels were stabilized under these conditions (Figure 
1B). Consistent with these results, the mRNA levels 
of the NF-κB target genes Tnfa, Il6 and Cox2 were not 
induced in MC-38 cells exposed to hypoxia (Figure 
3C). In conclusion, direct hypoxic induction of the NF-
κB signaling pathway does not appear to be a general 
phenomenon in carcinoma cells.
The Hif1a gene is not a transcriptional target of 
NF-κB in MC-38 colon cancer cells
Several previous reports have demonstrated that NF-
κB binds to the promoter of the Hif1a gene and activates 
its transcription in a limited number of cell types [18-21]. 
However, no significant change in HIF-1α mRNA (Figure 
4A) or protein (Figure 4B) levels could be detected in 
MC-38 cells treated with LPS, regardless of the oxygen 
concentration. These results were confirmed by the 
absence of any significant changes in the mRNA levels 
Figure 3: NF-κB signaling under hypoxic conditions. A. Immunofluorescence microscopy of p65/RelA in MC-38 cells following 
exposure to 0.2% oxygen for 0.5 to 4 hours. Treatment with 1 µg/ml LPS for 1 hour served as positive control. B. Immunoblot detection 
p65/RelA and the constitutive Sp1 transcription factors in MC-38 nuclear extracts following exposure to 1 µg/ml LPS or 0.2% oxygen for 
1 to 12 hours. C. RT-qPCR analysis of the regulation of the canonical NF-κB target genes Tnfa, Il6 and Cox2 following hypoxic exposure.
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of the canonical HIF target genes Glut1, Ca9 and Phd3 
(compare Figures. 1C and 4C). 
Knock-down of p65/RelA does not affect HIF 
signaling
To investigate whether NF-κB could be involved in 
basal rather than in conditional HIF-1α regulation, p65/
RelA was knocked-down by RNA interference. MC-38 
cells were stably transfected with a shRNA construct 
targeting p65/RelA, leading to an efficient decrease in p65/
RelA mRNA (Figure 5A) and protein (Figure 5B) levels. 
By contrast, HIF-1α mRNA (Figure 5A) and protein 
(Figure 5B) levels remained unaltered following p65/RelA 
knockdown. These results were further corroborated by 
mRNA quantification of the HIF target genes Glut1, Ca9 
and Phd3, which showed similar profiles in both shMOCK 
and shp65/RelA treated cells under normoxic as well as 
hypoxic conditions (Figure 5C).
Knock-down of HIF-1α does not affect NF-κB 
signaling
To investigate the converse possibility that HIF-
1α is involved in basal rather than conditional NF-κB 
regulation, HIF-1α was knocked-down by stable shRNA 
expression. Because another retroviral vector backbone 
was used, two different shMOCK controls were generated, 
termed shMOCK_A (Figure 6) and shMOCK_B 
(Figure 5) for comparison with shHIF-1α and shp65/
RelA, respectively. HIF-1α knock-down efficiency was 
confirmed on the mRNA (Figure 6A) and protein (Figure 
6B) levels. However, p65/RelA mRNA levels (Figure 
6A) and total p65/RelA protein (Figure 6B) remained 
unaltered in shHIF-1α treated cells under either normoxic 
or hypoxic conditions. As shown in Figure 6C, p65/
RelA nuclear translocation following LPS treatment also 
remained unaffected in HIF-1α knock-down MC-38 cells. 
These results were consistent with the mRNA regulation 
of the NF-κB target genes Tnfa and Il6, which showed no 
significant difference following induction by LPS for 1 to 
8 hours (Figure 6D).
Unexpected cross-talk between hypoxic and 
inflammatory pathways
In order to obtain a comprehensive picture of the 
transcriptome regulation by the interaction between 
hypoxic and inflammatory pathways, MC-38 cells were 
further characterized by RNA deep sequencing. In order 
to more closely recapitulate solid tumor conditions, 
Figure 4: HIF signaling under inflammatory conditions. A. RT-qPCR analysis of the HIF-1α mRNA response to LPS treatment in 
MC-38 cells. B. Kinetics of the HIF-1α protein response to LPS and/or hypoxia as assessed by immunoblotting of 50 µg total cell extracts. 
β-Actin served as loading control. C. RT-qPCR analysis of the effects of LPS treatment on the canonical HIF targets gene Glut1, Ca9 and 
Phd3.
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cells were cultured as small (approx. 250 µm diameter) 
three-dimensional (3D) spheroids in hanging drops. Of 
note, 3D spheroid conditions appeared to enhance the 
inflammatory response compared to conventional 2D sub-
confluent conditions in tissue culture plates. Following 
treatment with LPS, the TNF-α mRNA induction rose 
from 7-fold in 2D to 21-fold in 3D (supplementary Figure 
S1A). Although we and others previously found hypoxic 
conditions in the core of larger tumor spheroids [23], HIF-
1α remained largely unaffected in the relatively small MC-
38 3D spheroid cultures (supplementary Figure S1B). 
Stable shHIF-1α, shp65/RelA or shMOCK MC-38 
cells were cultured under 3D conditions for 48 hours, 
exposed to 0.2% oxygen for 8 hours and treated with 1 µg/
ml LPS for the last 1 hour of the hypoxic exposure. These 
dosages and time points were previously determined to be 
optimal for HIF-1 and NF-κB activation (see also Figures 
1 and 2). RNA deep sequencing and subsequent analysis 
was performed as described in the Materials and Methods 
section. Thresholds for induction and repression were 
chosen to be at least 1.5-fold or 0.67-fold, respectively. 
In the case of cells transfected with shHIF-1α or shp65/
RelA, “repression” and “induction” in comparison with 
shMOCK-transfected cells refers to genes positively 
and negatively regulated by HIF-1α and/or p65/RelA, 
respectively (supplementary Table S1). 
In summary, for the correct regulation of the 
majority of the hypoxically induced genes, not only was a 
functional HIF pathway required (72% of all tested genes 
required HIF) but also a functional NF-κB pathway (77%). 
While 59% of the genes induced by the inflammatory 
stimulus were dependent on NF-κB, only 18% required 
HIF. Finally, the number of genes induced by LPS under 
normoxic conditions was reduced by almost 50% under 
Figure 5: HIF signaling in p65/RelA knock-down cells. A. RT-qPCR analysis of HIF-1α and p65/RelA mRNA in MC-38 cells 
stably transfected with shp65/RelA or shMOCK_B negative control constructs. B. Immunoblotting of HIF-1α and p65/RelA protein after 
8 to 72 hours of hypoxic exposure of shMOCK_B or shp65/RelA MC-38 cells. β-Actin served as loading control. C. RT-qPCR analysis 
of the canonical HIF target genes Glut1, Ca9 and Phd3 in shMOCK_B or shp65/RelA MC-38 cells cultured under normoxic or hypoxic 
conditions as indicated.
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hypoxic conditions, suggesting that hypoxia attenuates the 
inflammatory response of MC-38 cells.
Role of HIF-1α in the suppression of 
proinflammatory gene expression by hypoxia?
A possible explanation for the attenuated 
inflammatory response under hypoxic conditions might 
be a HIF-1α dependent inhibition of proinflammatory 
gene expression. From the hypoxically suppressed 
proinflammatory genes identified by RNA sequencing, 
four secreted inflammatory factors (CCL20, CXCL5, 
CSF2 and TNFα) associated with tumor inflammation 
were chosen for further validation. Therefore, MC-38 cells 
were independently exposed to hypoxic (0.2% oxygen) 
and/or inflammatory (1 µg/ml LPS) conditions, followed 
by mRNA quantification and data analysis by two-way 
ANOVA (Figure 7). 
All four genes were strongly induced by 
inflammatory conditions. As expected, this induction is 
mediated by NF-κB since p65/RelA knock-down blocked 
their induction by LPS (data not shown). In contrast, 
hypoxia alone had diverse effects on these genes. While it 
did not affect CCL20, the mRNA levels of CXCL5, CSF2 
and TNFα were significantly altered by hypoxia. HIF-1α 
knock-down only affected the hypoxic impact on CXCL5 
but there were no changes for CCL20, CSF2 and TNFα 
between shMOCK and shHIF-1α cells.
Importantly, hypoxia significantly affected the 
inflammatory response of CXCL5, CSF2 and TNFα, 
while the hypoxic attenuation of the inflammatory CCL20 
induction did not quite reach statistical significance. 
Again, HIF-1α knock-down only prevented the cross-talk 
between inflammation and hypoxia of CXCL5, but not of 
CCL20, CSF2 and TNFα (Figure 7), suggesting that HIF 
is not a major pathway involved in the hypoxic attenuation 
Figure 6: p65/RelA signaling in HIF-1α knock-down cells. A. RT-qPCR analysis of HIF-1α and p65/RelA mRNA in MC-38 cells 
stably transfected with shHIF1α or shMOCK_A control constructs. B. Immunoblotting of HIF-1α and p65/RelA protein after 8 hours of 
hypoxic exposure of shMOCK_A or shHIF1α MC-38 cells. β-Actin served as loading control. C. Immunofluorescence microscopy of p65/
RelA in shMOCK_A or shHIF-1α MC-38 cells treated with 1 µg/ml LPS for 40 minutes. D. RT-qPCR analysis of the canonical NF-κB 
target genes Tnfa and Il6 in shMOCK_A or shHIF-1α MC-38 cells upon treatment with LPS for 1 to 8 hours. 
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of proinflammatory gene expression. Indeed, whereas 
hypoxia blocked the inflammatory induction of 136 out of 
277 LPS-induced genes, only 6 and 9 genes, respectively, 
were negatively regulated by HIF-1α under normoxic and 
hypoxic conditions (supplementary Table S1).
Hypoxia impairs LPS-stimulated NF-κB nuclear 
translocation by increasing IκBα levels
Since nuclear translocation is the key event in NF-
κB activation, p65/RelA subcellular localization was 
analyzed by immunofluorescence microscopy of 2D MC-
38 cultures. Interestingly, while LPS strongly induced p65/
RelA nuclear translocation, this was partially prevented 
by simultaneous hypoxic exposure in HIF-1α wild-type 
as well as knock-down cells (Figure 8A), suggesting 
that the observed block was dependent on hypoxia, but 
independent of HIF-1α. A similar result was obtained with 
3D MC-38 cultures (supplementary Figure S2). 
To elucidate the mechanism of impaired p65/RelA 
nuclear translocation, p65/RelA and IκBα were analyzed 
by co-immunofluorescence microscopy of MC-38 cells 
not containing the GFP gene (Figure 8B). Of note, IκBα 
immunofluorescence intensity appeared to be stronger 
under hypoxic than normoxic conditions (Figure 8B). 
A quantitative comparison of the number of cells with 
nuclear p65/RelA localization following LPS stimulation 
revealed an inverse association with IκBα. Consistent with 
the attenuated NF-κB response, more cells were IκBα 
positive under hypoxic conditions (Figure 8C). 
To corroborate these findings and to analyze the 
underlying mechanisms, both total and phosphorylated 
Figure 7: Interaction between inflammatory and hypoxic signaling. MC-38 shMock and shHIF-1α cells were exposed to 
hypoxia (0.2% oxygen) for 8 hours and treated with 1 µg/ml LPS for the last 1 hour of normoxic or hypoxic cell culture. CCL20, CXCL5, 
CSF2 and TNFα mRNA levels were quantified by RT-qPCR. Shown are mean values + SD of mRNA ratios relative to the constitutively 
expressed ribosomal protein S12 mRNA levels, normalized to the mean of each experiment (n = 6 independent experiments). Two-way 
ANOVA was used to assess the significance of the effects of inflammation (LPS) and hypoxia (0.2% oxygen) as well as of the interaction 
between these two conditions (i.e. the effect of hypoxia on inflammation). p values are indicated; n.s., not significant.
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IκBα and IKK protein levels were assessed by 
immunoblotting of MC-38 cells treated as in Figure 8B 
but with additional time points of LPS stimulation (Figure 
8D). Again, total IκBα protein was reproducibly increased 
by hypoxia alone. Consistently, a faint constitutive IκBα 
phosphorylation was detectable in unstimulated normoxic 
but not hypoxic cells. We further found a HIF-independent 
3-fold induction of IκBα mRNA levels by exposure to 
hypoxia alone for 8 hours (Figure 8E). Together, these 
results suggest that hypoxia might suppress inflammatory 
p65/RelA at least partially via pre-induction of its 
antagonist IκBα by both mRNA induction and increased 
protein stability.
Addition of LPS strongly stimulated IκBα 
phosphorylation after 15 minutes followed by a decrease 
in total (and hence also phospho-) IκBα protein levels after 
30 minutes. While the kinetics of IκBα phosphorylation 
appeared similar under normoxic and hypoxic conditions, 
Figure 8: Inverse regulation of NF-κB and IκB under hypoxic conditions. A. Immunofluorescence microscopy of p65/RelA 
in shMOCK and shHIF-1α MC-38 cells following exposure to 0.2% oxygen for 8 hours and/or 1 µg/ml LPS for the last 40 minutes before 
harvesting. B. Co-immunofluorescence microscopy of IκBα and p65/RelA in MC-38 cells (without GFP) exposed to 0.2% oxygen for 8 
hours and/or 1 µg/ml LPS for the last 30 minutes before harvesting. C. For fractional quantification of the results shown in B., at least 200 
cells of each experiment were classified according to the subcellular localization of p65/RelA and the expression of IκBα as indicated. D. 
Immunoblot analysis of total IκBα, phosphorylated IκBα, total IKKβ and phosphorylated IKKβ/α in MC-38GFP cells exposed to 0.2% 
oxygen for 8 hours and 1 µg/ml LPS for the last 5, 15 or 30 minutes as indicated. E. RT-qPCR analysis of IκBα mRNA levels in MC-38GFP 
cells exposed to 8 hours hypoxia and/or 1 hour LPS. Shown are mean values + SD of mRNA ratios relative to the constitutively expressed 
ribosomal protein S12 mRNA levels, normalized to the mean of each experiment (n = 6 independent experiments); *, p < 0.05; **, p < 0.01 
(Student’s t-test).
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the levels of total IκBα protein after 30 minutes were 
slightly higher under hypoxic conditions (Figure 8D), but 
the difference was not as pronounced as the increase in 
IκBα positive cell numbers at the same time point (Figure 
8C), suggesting differential kinetics of the regulation of 
IκBα protein stability by LPS on the single cell level. 
Interestingly, analysis of IKK phosphorylation, a 
surrogate marker for IKK-dependent IκBα kinase activity, 
revealed a much faster, transient IKK phosphorylation 
under hypoxic conditions (maximal at 15 minutes) than 
under normoxic conditions (maximal at 30 minutes). 
Lower IKK kinase activity after 30 minutes LPS 
stimulation under hypoxic conditions is consistent 
with increased IκBα levels, followed by attenuated 
proinflammatory gene expression.
DISCUSSION
Mortality of colorectal cancer patients has 
previously been demonstrated to be associated with 
high HIF-1α, but not HIF-2α, mRNA and protein levels 
[24, 25]. The mouse model of colorectal cancer used in 
this study shows similar features: HIF-2α mRNA levels 
in MC-38 colon adenocarcinoma cells were at least 
two orders of magnitude lower than the HIF-1α mRNA 
levels. Moreover, no HIF-2α protein could be detected 
under hypoxic conditions (data not shown) and the 
hypoxic response of the canonical HIF target genes Ca9 
and Phd3 was almost fully abrogated in shHIF-1α cells, 
demonstrating the lack of redundancy of the HIF response 
in these cells (supplementary Figure S3). This finding is 
in line with a recent report demonstrating that the HIF2A/
EPAS1 but not the HIF1A gene is epigenetically silenced 
in colonic adenocarcinoma specimens when compared 
with non-neoplastic tissue [26]. Therefore, shHIF-1α 
knock-down was sufficient to allow for the investigation 
of the role of the HIF signaling pathway in MC-38 cells. 
NF-κB plays an important role during colorectal 
cancer progression and NF-κB has been shown to be a 
prognostic factor negatively associated with survival 
in patients with metastatic colorectal cancer [25, 27]. 
Colorectal cancer cells are likely to be exposed to bacterial 
LPS, derived from the gut microbiota, which is known 
to activate NF-κB via Toll-like receptor 4 (TLR4). Both 
TLR4 and its adapter MyD88 are increased in human 
sporadic colon cancer compared to surrounding normal 
and adenomatous epithelium, and are associated with 
poor patient prognosis [28], thereby implying a functional 
role for the LPS-TLR4-NF-κB pathway in colon cancer. 
NF-κB signaling was robustly activated in the epithelial 
MC-38 colon cancer cells used in this study in response 
to treatment with LPS, making them a suitable model 
to study the cross-talk between the hypoxic and the 
inflammatory pathways in colon cancer.
Although MC-38 cells responded to LPS with 
nuclear p65/RelA translocation as well as NF-κB target 
gene expression, no transcriptional induction of HIF-1α 
mRNA could be observed, as has previously reported for 
several other cellular systems [18-22]. Even under 3D 
culture conditions, where we generally observed a stronger 
inflammatory response as compared to 2D cultures, no 
upregulation of HIF-1α mRNA could be detected upon 
NF-κB activation (data not shown). Similarly, four 
additional human colon cancer cell lines (COLO-741, 
HT-29, SW-620 and CX-1) showed no HIF-1α mRNA 
upregulation following LPS treatment (data not shown). 
In contrast, we observed a 6-fold upregulation of HIF-
1α mRNA in primary mouse peritoneal macrophages 
following LPS stimulation (supplementary Figure S4), 
strongly suggesting that transcriptional HIF-1α regulation 
by NF-κB is a cell type-specific phenomenon. However, 
the additional factors required to confer HIF-1α induction 
by NF-κB are currently unknown.
In contrast to several previous reports suggesting 
hypoxic NF-κB induction [11, 13, 15, 16], we found no 
increase in NF-κB activity upon acute (up to 4 hours) 
or chronic (up to 72 hours) hypoxic exposure of MC-38 
cells. Of note, only four of 32 different cancer cell lines 
have been shown to sustainably upregulate NF-κB activity 
during a prolonged (48 hours) exposure to hypoxia, and 
this effect required the HPV-encoded E6 protein. Just 
a few HPV-negative cell lines showed a moderate and 
transient (up to 3 hours) induction of NF-κB activity upon 
exposure to hypoxia [14].
Regarding the absence of proinflammatory HIF-
1α and hypoxic NF-κB induction in MC-38 colon cancer 
cells, we were surprised to find that under the same 
conditions, RNA deep sequencing revealed that 77% of 
the hypoxically induced genes required p65/RelA and still 
18% of the inflammatory genes required HIF-1α. There are 
a number of genes known which have been reported to be 
regulated by both HIF-1 and NF-κB, including NOS2 [29], 
IL1B [30, 31], COX2 [16] and PKM2 [32]. However, it is 
unlikely that HIF cooperates with NF-κB on virtually all 
of its target genes, and it seems more likely that epigenetic 
mechanisms might be the basis of this mutual cooperation 
[33, 34].
Rather than inducing NF-κB, hypoxia attenuated the 
proinflammatory response to LPS in MC-38 cells cultured 
under 2D and 3D conditions. RNA deep sequencing 
and RT-qPCR analysis of NF-κB target genes revealed 
only a minor role for HIF-1α in the decreased hypoxic 
induction of a few NF-κB target genes. A direct repressive 
HIF function is unlikely because genome-wide DNA 
association studies combined with transcriptional profiling 
and assessment of histone marks clearly revealed a 
transcriptional enhancer but no repressor function of both 
HIF-1α and HIF-2α [35]. 
Our findings are in line with two earlier studies 
performed using macrophages and synovial fibroblasts, 
respectively, which demonstrated that chemical hypoxia 
attenuated NF-κB dependent inflammatory genes induced 
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by LPS but not by other proinflammatory stimuli [36, 
37]. PHD oxygen sensing enzymes have been shown 
to be both positively and negatively implicated in NF-
κB activation. PHD1 negatively regulates IκB kinase-β 
in HeLa cells, and PHD3 is a negative regulator of NF-
κB in skeletal myoblast differentiation [13, 38]. On 
the other hand, LPS-induced cytokine expression in 
macrophages was suppressed by treatment with the PHD 
inhibitor dimethyloxalylglycine (DMOG) or siRNA-
mediated knockdown of PHD1 and PHD2 [36]. DMOG 
pretreatment also attenuated the systemic LPS-induced 
activation of the NF-κB pathway and prevented endotoxic 
shock [39].
Quite unexpectedly, hypoxia inhibited the LPS-
mediated nuclear translocation of p65/RelA in a HIF-
independent manner. Apparently, hypoxia alone induced 
IκBα on both the mRNA and protein levels, and the 
activation of IKK kinase activity by LPS was of more 
transient nature under hypoxic than normoxic conditions, 
resulting in decreased IKK phosphorylation, slightly 
increased IκBα protein levels and clearly increased IκBα 
positive cell numbers after 30 minutes of LPS treatment. 
While these findings explain the attenuated inflammatory 
response, it still remains unclear as to how hypoxia 
attenuated IKK phosphorylation. Interestingly, it has 
recently been suggested that inhibition of the oxygen-
dependent PHD1 and FIH protein hydroxylases blocks IL-
1β signaling components of the TRAF6 complex involved 
in NF-κB activation [40]. Whether similar mechanisms are 
involved in the hypoxic attenuation of the LPS response 
needs to be investigated.
Both, the hypoxic and the inflammatory pathways 
are becoming increasingly well recognized as useful 
tools in cancer diagnosis as well as in tumor therapy [1]. 
Our results demonstrate a complex interplay between 
these two pathways in colon cancer cells. Whereas 
direct transcriptional cross-talks between HIF-1α and 
p65/RelA could not be confirmed in this cell type, 
strong indirect interactions between the two pathways 
could be demonstrated, suggesting that these two 
microenvironmental stimuli should always be considered 




Mouse colon adenocarcinoma MC-38 GFP (if not 
indicated otherwise, referred to as “MC-38”) cells [41] 
were cultured in high glucose DMEM medium (Sigma, 
St. Louis, MO, USA; or Gibco, Carlsbad, CA, USA) 
supplemented with 10% FCS (Gibco), 50 IU/ml penicillin 
and 100 µg/ml streptomycin. MC-38 3D spheroid cultures 
were grown in hanging drops in 60-well microtest plates 
(Greiner, Frickenhausen, Germany) by seeding 2500 
cells/25 µl drop 48 hours before the experiment. For 
hypoxia experiments, cells were grown in a gas-controlled 
workstation (InvivO
2
 400, Ruskinn Technologies, 
Pencoed, UK). For inflammatory stimulation, MC-38 
cells were treated with 1 µg/ml LPS derived from E.coli 
(Sigma). Before LPS treatment, 2D but not 3D cultures 
were starved overnight in 0.1% FCS.
mRNA quantification
Total cellular RNA was extracted as described 
[42] or by using the Nucleospin RNA II extraction 
kit (Macherey-Nagel, Düren, Germany). cDNA was 
synthesized from 1-2 µg of total RNA using Affinity Script 
reverse transcriptase (RT) (Agilent Technologies, Santa 
Clara, CA, USA). Quantitative (q) PCR was performed 
using SybrGreen master mix (Sigma) on a MX3000P light 
cycler (Agilent Technologies). Primers were purchased 
from Microsynth (Balgach, Switzerland) and are listed 
in supplementary Table S2. RNA sample quality and 
equal inputs were assessed by RT-qPCR quantification of 
ribosomal protein S12 mRNA, and all data were expressed 
as ratios over S12 mRNA. 
Protein extraction and immunoblotting
Cells were washed twice with ice-cold PBS by 
centrifugation for 3 minutes at 1200 rpm. For total protein 
extraction, cells were resuspended in lysis buffer (10 mM 
Tris-HCl pH 8.0, 1 mM EDTA, 400 mM NaCl, 0.1% 
NP-40, freshly added 1 mM PMSF and Sigma’s Protease 
Inhibitor Cocktail; Sigma’s Phosphatase Inhibitor Cocktail 
was added for phospho-protein detection). For nuclear 
protein extraction, cells were resuspended in hypotonic 
buffer (10 mM HEPES/KOH pH 7.9, 10 mM KCl, 0.1 mM 
EDTA, 0.1 mM EGTA with freshly added 1 mM PMSF). 
After 15 minutes on ice, NP-40 was added to a final 
concentration of 0.1% and the samples were immediately 
vortexed for 20 seconds. Nuclei were pelleted for 30 
seconds at 5000 rpm, washed with hypotonic buffer and 
extracted on ice in hypertonic extraction buffer (20 mM 
HEPES/KOH pH 7.9, 400 mM NaCl, 1mM EDTA, 1mM 
EGTA and protease inhibitors) for 10 minutes. Proteins 
were separated by 10% SDS-PAGE, electrotransferred 
to PVDF membranes and detected using anti-p65/RelA 
(Santa Cruz Biotechnology, Dallas, TX, USA), anti-
HIF-1α (Novus Biologicals, Littletone, CO, USA), anti-
HDAC1 (Abcam, Cambridge, UK), anti-SP1 (Santa Cruz 
Biotechnology), anti-phospho-Ser176/180-IKKα/β anti-
IKKβ, anti-phospho-Ser32/36-IκBα and anti-IκBα (all 




Following fixation with 4% paraformaldehyde 
for 30 minutes at room temperature, MC-38 cells were 
washed twice with PBS, permeabilized with 0.1% saponin, 
free aldehyde groups quenched with 20 mM glycine, and 
unspecific binding sites blocked with 10% FCS for 30 
minutes. Proteins were detected by incubation for 1 hour 
at 37°C with anti-p65/RelA (Santa Cruz Biotechnology) 
or anti-IκBα (Cell Signaling Technology) antibodies. After 
washing with PBS, the respective secondary antibodies 
labeled with Cy3 (Jackson Immunoresearch, West Grove, 
PA, USA), Alexa488 or Alexa568 (Molecular Probes, 
Carlsbad, CA, USA) were applied, and nuclei were 
counter-stained with DAPI. Samples were mounted using 
Mowiol (Millipore, Darmstadt, Germany) and analyzed 
by fluorescence microscopy. Spheroids were fixed in 
10% formalin for 30 minutes at room temperature and 
processed for histological analysis using previously 
described techniques [43]. Dewaxed paraffin sections 
(5 µm) were rehydrated, blocked with 10% normal goat 
serum and processed as described above. 
RNA interference
Knock-down of specific mRNAs was achieved 
by lentiviral transduction of short hairpin RNA 
(shRNA) vectors driven by the U6 promoter in the 
pLKO.1-puro plasmid (Sigma). Vectors targeting 
mouse HIF-1α (shHIF1α) and non-target controls 
(shMOCK_A) were purchased from Sigma. To construct 
the shp65 vector, the oligonucleotides 5’- gat cccca 
gggcaaactgtagagtcattcaagagatgactctacagtttgcccttttttggaaa   
-3’and 5’-agcttttcc 
aaaaagggcaaactgtagagtcatctcttgaatgactctacagtttgccctggg 
-3’ were annealed, phosphorylated and ligated into the 
pSUPER vector. A BamHI/SalI fragment of the H1-RNA 
promoter was ligated into the pRDI292 vector (kind 
gift from P. O. Hassa, Zurich, Switzerland) and used for 
expression of shp65.
RNA sequencing and data deposition
RNA was extracted and pooled from 3 independent 
3D-cultures grown under hypoxic or normoxic conditions. 
Ribosomal RNA in the pooled RNA was depleted using 
Encore Complete RNA-Seq Library Systems (NuGEN, 
San Carlos, CA, USA) and RNA was sequenced using an 
Illumina HiSeq 2000 sequencer (San Diego, CA, USA) 
at the Functional Genomics Center Zurich. Isoform 
and gene expression levels were computed with RSEM 
(Version 1.2.0; http://www.biomedcentral.com/1471-
2105/12/323). RSEM was run in stranded mode with the 
additional option to estimate the distribution of the read 
start positions. The expression levels (RSEM’s posterior 
estimate of the read counts per transcript normalized for 
gene length) were normalized across samples using the 
geometric mean of all expression signals. To attenuate 
expression ratios for low abundance genes, a fixed value 
of 5 was added to all expression values before computing 
the log-ratio. Threshold levels for hypoxia- or LPS-
dependent up- or down-regulation were set at >1.5 or 
<0.67, respectively, as were the threshold levels for HIF-
1α or p65/RelA dependency of up- or down-regulated gene 
expression when compared to the respective shMOCK 
controls. Only genes with a minimal expression level of 
10 were considered biologically relevant. All data were 
deposited in the Short Read Archive (SRA) of the NCBI 
and are accessible through the ID SRP043151.
Statistical analysis
Unless indicated otherwise, all experiments were 
repeated at least three times independently. Data are 
shown as mean values + SD. Student’s t-tests or two-way 
ANOVA were applied to analyze the data as indicated, 
with a p-value < 0.05 considered to be statistically 
significant.
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